The Evaluation of the Effect of Performing Guided Lid Surgery

NCT ID: NCT05358275

Last Updated: 2022-05-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

18 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-10-01

Study Completion Date

2023-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

to evaluate the percentage of bone volume regain along with postoperative pain in cases done using the bone lid technique in comparison with those done using the conventional cyst enucleation technique.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study will involve eighteen patients selected from the outpatient clinic, Oral and Maxillofacial Surgery Department, Faculty of Dentistry, Ain Shams University.

The patients included in this study will be informed about the full details of this research and they will sign an informed consent. Moreover, this research will be reviewed by the research ethics committee, Faculty of Dentistry, Ain Shams University.

Randomization:

The study consists of two groups each containing 10 patients. Patients will be randomly allocated according to predetermined computer-generated randomization using (www.randomizer.org).

PICO:

P: Patients with expansile cystic lesions with intact bony cortex of a minimum 1mm thickness.

I: Cyst enucleation using the bone lid technique and piezoelectric device. C: Cyst enucleation using the conventional buccal bone ostectomy technique. O: Percentage of bone volume recovery. T: 6 months postoperative.

Inclusion criteria:

1. Age ranging from 18-60 years.
2. Have free medical history or controlled systemic disease.
3. Expansile cystic lesion with intact cortical bone extending from 2-6 teeth.
4. A minimum thickness of 1 mm of the cortical bone.

Exclusion criteria:

1. Patients with history of surgery in the area affected by the cystic lesion.
2. Patients with suspected malignant tumors in the area.

Pre-operative assessment:

Proper history is obtained followed by palpation of the affected area to check tenderness or suspected superimposed infection. Aspiration biopsy is done to ensure the nature of the lesion being cystic. Cone Beam Computed Tomography (CBCT) is done to assess the exact size of the lesion and plan for the surgical cutting guide.

Patients with intact cortical bone related to the cystic lesion will be enrolled in this study. All patients will receive full information about the procedures where the risks and benefits will be thoroughly explained to them. They will then be asked to give their consent.

Sample size calculation:

Considering that there was around 93% difference between the cystic cavity before and after lid surgery with enucleation (19). After setting the α at 0.05 and β at 0.2; the minimal sample size was calculated and revealed that the minimum number to achieve statistical data was 10 patients in each goup (total number of patients= 20).

Pre-operative patient preparation:

1. Fasting for 6-8 hours before the procedure.
2. Laboratory investigations to assess his/ her medical condition if the procedure is to be performed under general anesthesia;

* Complete blood count (CBC).
* Bleeding profile; PT, PTT, INR.
* Liver function test.
* Kidney function test.
* Blood sugar level; fasting and 2-hours post-brandial.

Surgical procedure:

Anesthetizing the surgical area is done using the selected suitable nerve block technique with articaine 4% and 1:100,000 epinephrine.

1. Flap reflection:

A full thickness muco-periosteal flap is reflected using no.15 blade. The extent of the flap incisions shall involve one tooth mesial to the lesion and one tooth distal to the lesion.
2. Surgical guide fixation:

The surgical cutting guide is adapted in place and fixed using micro-screws to ensure proper stability of the guide and accuracy of the bony window.
3. Bone lid fabrication:

The bony window is cut guided by the edges in the cutting guide using piezoelectric device under copious irrigation. The window is then dissected bluntly from the attached cystic lesion using a muco-periosteal elevator and a bone curette.
4. Enucleation of the cystic lesion:

The lesion is carefully separated from the surrounding bone using a muco-periosteal elevator and a bone curette while being held with a toothed tissue forceps or Allis forceps. The excised lesion will be placed in a jar containing 10% formaldehyde to be sent to the Oral Pathology lab for excisional biopsy confirmation of the nature of the lesion. This is followed by careful curettage of the surgical bed to ensure absence of any remnants of the lesion followed by rinsing using isotonic saline solution.
5. Fixation of the bone lid:

The previously removed bone lid is reoriented back in place and fixed using 2.3 micro-plates and micro-screws for rigid fixation.
6. Closure of the flap:

The flap is sutured using 4-0 vicryl resorbable suture to achieve primary closure.

The control group will be done using the conventional buccal ostectomy technique by reflection of a full thickness mucoperiosteal flap followed by removal of part of the cortical bone to allow enough access to the cystic lesion. The lesion is enucleated afterwards by removing the entire lining and the flap is closed at the end of the procedure using 4-0 vicryl resorbable suture. No surgical guide is used and the removed part of the cortical bone is grinded using a high speed handpiece, a rounded surgical bur and a bone curette.

Immediate post-operative medications:

1. Amoxicillin/ clavulanate 1gm tablets every 12 hours for 5 days.
2. Chymotrypsin 300E.A.U. 2 tablets every 8 hours for 5 days.
3. Ibuprofen 600mg tablets every 12 hours for 5 days.

Immediate post-operative instructions:

1. Avoid vigorous rinsing or spitting for the first 24 hours.
2. Place ice packs over the surgical area for 10 minutes and repeated every 30 minutes over the first 6 hours.
3. Avoid hot, hard or crunchy food for the first 3 days.
4. After 24 hours, start rinsing with warm isotonic saline solution 3 times per day for 7 days.
5. After 24 hours, start placing warm packs over the surgical area 3 times per day for 7 days.

Follow up:

1. Percentage of bone volume regained will be evaluated using CBCT 6 months after the intervention (a total of 2 CBCTs; one pre-operative and one 6 months post-operative).
2. Pain will be assessed immediately postoperative and after 6 months by Visual Analog Scale from (0-10), as 0 means absence of pain and 10 means maximum pain.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Odontogenic Cysts

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized clinical trial with 1:1 allocation ratio
Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors
Double blinded

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

study group

Guided lid surgery is performed to reduce the loss of bone post operative

Group Type EXPERIMENTAL

surgical cutting guide with piezo

Intervention Type DEVICE

3D planned lid surgery

control group

The patient will receive active ordinary treatment for removal of odontogenic cysts

Group Type ACTIVE_COMPARATOR

control

Intervention Type OTHER

ordinary cyst enucleation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

surgical cutting guide with piezo

3D planned lid surgery

Intervention Type DEVICE

control

ordinary cyst enucleation

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Age ranging from 18-60 years.
2. Have free medical history or controlled systemic disease.
3. Expansile cystic lesion with intact cortical bone extending from 2-6 teeth.
4. A minimum thickness of 1 mm of the cortical bone.

Exclusion Criteria

1. Patients with history of surgery in the area affected by the cystic lesion.
2. Patients with suspected malignant tumors in the area.
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ain Shams University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Yasser Mohamed Nabil Ahmed Khirat El Hadidi

principle investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

mohamed diaa

Role: STUDY_CHAIR

Ain Shams University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ain shams University

Cairo, , Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

yasser el hadidi

Role: CONTACT

+201006596242

Marwa El Kassaby

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Marwa El Kassaby

Role: primary

01006596242

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

28-4-2022 OMFS

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.